Towa EU
Towa Pharma Italy,
Spain and Portugal
Europe
We specialize in complex generics and value-added medicines as the main areas
of our know-how. In addition, we are enhancing our food supplements and OTC
portfolio.
Through our work we seek to contribute to the sustainability of public health systems, equitable access to medicines and to create a healthy environment for future generations. We are committed to research, development and constant innovation of our products, in order to obtain safe and effective medicines and OTC products that meet the expectations of health professionals and society.
We market products that facilitate access to different treatments, helping to rationalize healthcare resources to ensure people’s health and quality of life.
We adapt to the needs of health professionals, doctors and pharmacists, offering them support and information so that they can develop their professional activity in an optimal way.
In 2022, we renamed our three commercial subsidiaries, which are now unified under the name Towa Pharmaceutical. We continue to market certain products under our well-known brands – Pensa in Spain and Italy, and Tolife in Portugal – as we plan a gradual and voluntary transition, always with our patients’ best interests in mind.
Our recent milestones:
We recently received certification from the Pharmacy Department at the Ministry of Health of the State of Libya for the manufacture of non-sterile solid medicines and their distribution in the country, giving us access to the North African market for the first time.
We have expanded our portfolio to include food supplements and over-the-counter medicines, featuring packaging with QR codes that allow users to access the leaflet in 8 different languages. This makes the information more accessible and easier to understand for non-native speakers. These efforts contribute to improving citizens’ quality of life through responsible self-care, while also supporting the sustainability of the healthcare system.
In 2024, we launched the first blood-based self-diagnostic pregnancy test with lab-comparable results. This all-in-one patented device is made possible through our partnership with NG Biotech.
